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Syntaxin 7 is a mammalian target soluble N-ethylma-
leimide-sensitive factor attachment protein receptor
(SNARE) involved in membrane transport between late
endosomes and lysosomes. The aim of the present study
was to use immunoaffinity techniques to identify pro-
teins that interact with Syntaxin 7. We reasoned that
this would be facilitated by the use of cells producing
high levels of Syntaxin 7. Screening of a large number of
tissues and cell lines revealed that Syntaxin 7 is ex-
pressed at very high levels in B16 melanoma cells. More-
over, the expression of Syntaxin 7 increased in these
cells as they underwent melanogenesis. From a large
scale Syntaxin 7 immunoprecipitation, we have identi-
fied six polypeptides using a combination of electros-
pray mass spectrometry and immunoblotting. These
polypeptides corresponded to Syntaxin 7, Syntaxin 6,
mouse Vps10p tail interactor 1b (mVti1b), a-synapto-
some-associated protein (SNAP), vesicle-associated
membrane protein (VAMP)8, VAMP7, and the protein
phosphatase 1M regulatory subunit. We also observed
partial colocalization between Syntaxin 6 and Syntaxin
7, between Syntaxin 6 and mVti1b, but not between Syn-
taxin 6 and the early endosomal t-SNARE Syntaxin 13.
Based on these and data reported previously, we pro-
pose that Syntaxin 7/mVti1b/Syntaxin 6 may form dis-
crete SNARE complexes with either VAMP7 or VAMP8
to regulate fusion events within the late endosomal
pathway and that these events may play a critical role in
melanogenesis.
In eukaryotic cells, proteins are transported between intracel-
lular organelles by a series of membrane transport steps. The
ability of discrete organelles to fuse in a highly specific way is
central to all membrane-trafficking events and relies on a series
of molecular events. One event is the formation of a protein
complex between sets of molecules found within the transport
vesicle (v-SNAREs)1 and the target membrane (t-SNAREs).
Much of the work that has led to the formulation of this hypoth-
esis has been performed in the mammalian synapse (1). Here the
R- or v-SNARE, VAMP2, forms a complex with two Q- or t-
SNARE proteins, Syntaxin 1a and SNAP25. This ternary com-
plex consists of a four-a-helical bundle containing one helix from
both Syntaxin 1a and VAMP2 with the remaining two helices
being contributed by SNAP25 (2). SNARE complexes that regu-
late traffic to the cell surface in both mammalian and yeast cells
contain three distinct proteins, whereas most intracellular
SNARE complexes appear to be comprised of four separate pro-
teins: one v-SNARE and three t-SNAREs (3, 4). For example, in
Saccharomyces cerevisiae endoplasmic reticulum to Golgi trans-
port is regulated by the Sed5pzBos1pzSec22pzBet1p complex,
whereas vacuolar transport is regulated by a complex comprising
Vam3pzVam7pzVti1pzNyv1p (3). The Syntaxin isoform, or t-
SNARE heavy chain (3), associated with each complex appears
to be highly specific to a particular vesicle transport step,
whereas the light chain t-SNAREs associate with multiple com-
plexes. Vti1p, for example, interacts with Syntaxin homologs
involved in Golgi/endosome, intra-Golgi, vacuolar, and prevacu-
olar transport steps (5).
Sequencing projects are revealing the existence of an ever
increasing number of SNARE family members (6). In the yeast
S. cerevisiae there are eight different Syntaxin-like proteins,
and in mammalian cells, at least 20 have been identified to
date (7, 8). A major challenge is to establish which transport
steps each of these proteins regulates. This will require estab-
lishing the intracellular location of these proteins as well as
their binding partners. Syntaxins 1, 2, 3, and 4 localize to the
plasma membrane (9); Syntaxin 5 operates between the endo-
plasmic reticulum and the Golgi apparatus; and Syntaxins 6, 7,
8, 13, and 16 are found in the endosomal system of mammalian
cells (10–14).
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The present study focuses on Syntaxin 7. Syntaxin 7 is
localized to compartments within the endosomal system where
it regulates transport between the late endosome and the lyso-
some (14–16). We have reported previously that Syntaxin 7
interacts with at least one v-SNARE, VAMP8 (14). Recent
analysis of VAMP8 has demonstrated a requirement for this
v-SNARE in the homotypic fusion of both early endosomes and
late endosomes (17). Another v-SNARE, VAMP7, has also been
implicated in late endosomal transport (16, 18), but its rela-
tionship to Syntaxin 7 has not yet been explored. This high-
lights the need for a more thorough characterizaton of Syntaxin
7 binding partners. The aim of the present study was to identify
Syntaxin 7-binding proteins using a biochemical approach. To
this end, we took advantage of the fact that Syntaxin 7 is
expressed at very high levels in the melanoma cell line, B16.
Using B16 cells as a source of Syntaxin 7, we used an immu-
noprecipitation approach combined with mass spectrometry to
identify mVti1b, Syntaxin 6, and a-SNAP as Syntaxin 7-bind-
ing proteins. In addition, we find that Syntaxin 7 forms a
complex with both VAMP7 and VAMP8, suggesting that the
t-SNARE Syntaxin 7 may regulate distinct fusion events
within the endocytic pathway by associating with distinct sub-
sets of partner SNARE proteins.
MATERIALS AND METHODS
Cells and Membrane Preparation—B16 Melanoma cells were kindly
provided by Dr. Peter Parsons (QIMR, Brisbane, Australia) and were
cultured in RPMI medium (Life Technologies, Inc.) supplemented with
10% fetal calf serum (Life Technologies, Inc.). For immunoblot analysis,
total membranes were prepared as follows. Cells were lysed by passage
through a 27-gauge needle in HES buffer (20 mM Hepes, 0.5 mM EDTA,
250 mM sucrose) containing protease inhibitors (10 mg/ml leupeptin, 10
mg/ml aprotinin, and 250 mM phenylmethylsulfonyl fluoride) before
centrifugation at 150,000 3 g for 30 min. The membrane pellet was
resuspended in HES buffer containing 1% Triton X-100 and incubated
on ice for 1 h, after which insoluble material was removed by centrifu-
gation at 17,500 3 g for 10 min. Triton X-100-soluble extracts of rat
tissues, obtained from male Wistar rats, were prepared by homogeni-
zation of the relevant tissues in HES buffer containing protease inhib-
itors. Homogenates were incubated for 30 min at 4 °C in the presence of
1% Triton X-100, after which insoluble material was removed by cen-
trifugation at 17,500 3 g for 10 min.
Antibodies, Plasmids, and Immunoblot Analysis—Polyclonal anti-
serum against mouse Syntaxin 7 was obtained by immunizing rabbits
with a chimeric protein consisting of the cytosolic domain of Syntaxin 7
fused to GST (pGST-Syn7a) (14). Antibodies raised against the GST
portion of the antigen were removed by passing the antiserum over a
column of GST linked to Affi-Gel (Bio-Rad). The flow-through from this
column was subsequently passed over a second column made by cou-
pling the GST-Syn7antigen to Affi-Gel. Syntaxin 7-specific antibodies
were eluted from this column with 100 mM glycine, 150 mM NaCl (pH
2.8). These affinity-purified antibodies were then titrated to pH 7.5
using Tris-HCl (pH 8). The VAMP8 antibodies have been described
previously (14). Antibodies to VAMP7 were raised against GST fusion
protein containing the entire cytosolic portion of VAMP7, which was
expressed from pPL815. Similarly, antibodies against Syntaxin 6 were
raised by immunizing rabbits with a GST protein containing the entire
cytosolic tail of this protein (pGST-Syn6; 14) or were purchased from
Transduction Laboratories. A plasmid encoding the cytosolic tail of
human Syntaxin 13 fused to GST and an antibody produced against this
fusion protein were kindly provided by Dr. R. Teasdale (Institute for
Molecular Bioscience, University of Queensland). The EEA1 antibody
was the generous gift of Dr. Ban Hock Toh (Monash Medical School,
University of Melbourne, Australia). Antibodies against mVti1b (19)
were kindly provided by Dr. G. Fischer von Mollard (University of
Gottingen, Germany). Antibodies against cytosolic domains of Syntaxin
4 and VAMP3 have been described previously (20). Membrane samples
were subjected to SDS-PAGE and subsequently transferred to polyvi-
nylidene difluoride membranes. Membranes were blocked in 1% (w/v)
non-fat dried milk and then incubated with primary antibodies in
phosphate-buffered saline containing 0.1% (v/v) Tween 20 and 1% (w/v)
non-fat dried milk for 1 h at room temperature at dilutions that were
optimized for each antibody. Visualization of antibody-labeled bands
was achieved with the use of horseradish peroxidase-labeled secondary
antibodies purchased from Amersham Pharmacia Biotech, and Super-
signal Dura chemiluminescent substrate was from Pierce. Immunoblot-
ting competition assays were performed by including the relevant GST
fusion protein antigen (100 mg/ml) during incubation with the primary
antibody. The GFP-Syn6 plasmid that encodes the full-length murine
Syntaxin 6 fused to the C terminus of enhanced GFP (eGFP) was a kind
gift from Dr. Jeffrey Pessin (University of Iowa) (21).
Immunofluorescence Microscopy—Cells were grown to 70% conflu-
ence on glass coverslips and fixed in 2% paraformaldehyde for 30 min.
In some cases B16 cells were transiently transfected with the GFP-
Syntaxin 6 vector using the LipofectAMINE reagent according to the
manufacturer’s instructions (Life Technologies, Inc.). This plasmid gen-
erated a protein of the expected molecular mass (;60 kDa) which could
be specifically immunoblotted with antibodies specific for either Syn-
taxin 6 or GFP (data not shown). After fixation, cells were quenched for
5 min in 150 mM glycine, washed in phosphate-buffered saline, and
permeabilized with 0.2% Triton X-100 in phosphate-buffered saline for
15 min. After blocking coverslips with 2.5% normal swine serum for 30
min at room temperature primary antibody incubations were performed
in 1% normal swine serum in phosphate-buffered saline for 1 h at room
temperature, followed by an appropriate fluorescein isothiocyanate- or
Texas Red-labeled secondary antibody (Molecular Probes, Eugene, OR)
for 30 min at room temperature. Cells were viewed using a 633/1.4
Ziess oil immersion objective on a Zeiss Axiovert fluorescence micro-
scope, equipped with a Bio-Rad MRC-600 laser confocal imaging sys-
tem. Images were imported into Adobe Photoshop™ (Adobe Systems
Inc.) and assembled as indicated.
Immunoprecipitation—Affinity matrices were prepared by first bind-
ing antibodies (affinity-purified anti-Syn7 antibodies with or without
an excess of GST-Syn7 fusion protein and purified rabbit IgG antibod-
ies) to protein A-Sepharose beads (Amersham Pharmacia Biotech).
Antibodies were covalently cross-linked to protein A beads using di-
methyl pimelimidate (Pierce). Triton X-100-soluble membrane extracts
prepared from B16 cells, which had been cultured for 7 days, were
prepared as outlined above and incubated with antibody-coated beads
for 1 h in the presence of 150 mM NaCl, 20 mM Hepes, and 0.5 mM
EDTA. The beads were washed in the same buffer containing 1%
Nonidet P-40. Elution of bound proteins was achieved by boiling for 10
min in Laemmli sample buffer containing 4% SDS. Proteins were sep-
arated on a 5–15% SDS-polyacrylamide gradient gel and visualized by
staining with either silver or Coomassie Brilliant Blue. Individual
protein bands were excised and subjected to sequence analysis.
Protein Sequencing and Mass Spectrometer Analysis—In-gel proteo-
lytic digestion (using 0.5 mg of trypsin) of resolved proteins was per-
formed as described previously (22). An electrospray ionization ion trap
mass spectrometer (LCQ Finnigan MAT, San Jose, CA) coupled on-line
with a capillary HPLC (Hewlett-Packard model 1090A) modified for
capillary chromatography was used for peptide sequencing. The column
used in this study was a 150 3 0.20-mm (inner diameter) capillary
column (Brownlee RP-300, 7 mm C8) manufactured using a polyvinyli-
dene difluoride end frit A 60-min linear gradient (flow rate 1.7 ml/min)
was used from 0–100% B, where solvent A was 0.1% v/v aqueous
trifluoroacetic acid, and solvent B was 0.1% aqueous trifluoroacetic acid
in 60% acetonitrile. The electrospray ionization parameters were as
follows: spray voltage, 4.5 kV; sheath gas and auxiliary gas flow rates,
5 and 30 (arbitrary value), respectively; capillary temperature, 150 °C;
capillary voltage, 20 V; and tube lens offset, 16 V. The sheath liquid
used was 2-methoxyethanol (99.9% HPLC grade) delivered at a flow
rate of 3 ml/min. The electron multiplier was set to 2860 V. In both MS
and MS/MS modes, the trap was allowed a maximum injection time of
up to 200 ms. The automatic gain control parameter was turned on for
all experiments, ensuring that the number of ions in the trap was
automatically kept to a constant preset value. The range scanned in MS
mode was 350–2,000 kDa, and in MS/MS the range varied according to
the mass of the ion selected for MS/MS. After acquiring one scan in MS,
the most intense ion in that spectrum above a threshold of 1 3 105 was
isolated for subsequent zoom scan (to determine charge state), then
collision-induced dissociation or MS/MS in the following scans. The
dissociation energy for MS/MS was set to 55%. All spectra were re-
corded in centroid mode. The sequences of individual peptides were
identified using the SEQUEST algorithm (incorporated into the Finni-
gan Xcalibur-Biomass software) (23). Spectra not identified by
SEQUEST were interpreted manually using de novo methods.
RESULTS
Specificity of the Syntaxin 7 Antibody—A Syntaxin 7-specific
antibody was raised against a bacterial fusion protein contain-
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ing the cytosolic tail (residues 1–234) of Syntaxin 7 fused to
GST. Antibodies that specifically recognize the Syntaxin 7 por-
tion of this fusion protein were affinity purified as described
under “Materials and Methods.” This antibody recognizes one
band of molecular mass 40 kDa (Fig. 1A, lane 1). Immunola-
beling of this band was completely inhibited in the presence of
an excess of the GST-Syn7 antigen (lane 2). In contrast, a
fusion protein consisting of the analogous region of Syntaxin 13
fused to GST had no significant effect on the recognition of this
band (lane 3). In addition, the mobility of the polypeptide
recognized by the Syntaxin 7 antibody was significantly differ-
ent from the bands labeled with antibodies specific for either
Syntaxin 13 or Syntaxin 6 (Fig. 1A, lanes 4 and 5). To validate
further the specificity of the Syntaxin 7 antibody we performed
immunofluorescence microscopy using B16 melanoma cells.
The antibody labeled a tubulovesicular compartment that was
concentrated in the perinuclear region of the cell (Fig. 1B). This
labeling was not significantly different upon inclusion of excess
GST-Syn13 fusion protein. However, in the presence of excess
GST-Syn7 the immunolabeling was almost completely absent,
consistent with the immunoblotting data (Fig. 1A). Collec-
tively, these data show that our Syntaxin 7 antibody is specific
and does not recognize other closely related Syntaxin isoforms.
Syntaxin 7 Is Expressed at High Levels in B16 Cells—We
have shown previously that Syntaxin 7 is widely expressed in
rodent tissues and that it regulates a membrane transport step
within the late endosome/lysosomal system of mammalian cells
(14). In view of this function we reasoned that cell types that
are specialized for late endosomal/lysosomal biogenesis might
up-regulate the machinery that is involved in these transport
steps. Melanocytes are a specialized cell type whose primary
function is the biogenesis of melanosomes, which represent
lysosome-like organelles (24). Consistent with this notion is our
finding that the levels of the Syntaxin 7 protein in the B16
melanosome cell line is ;10-fold higher than in all other tis-
sues and cell lines tested (Fig. 2). In contrast, the level of
Syntaxin 4, which localizes to the plasma membrane, was
much more uniform across all tissues and cell types, including
B16 cells. A similar uniformity was observed for Syntaxin 6
(Fig. 2) and Syntaxin 13 (data not shown) across these tissues
and cell types. Intriguingly, VAMP8, a v-SNARE that has also
been implicated in late endosomal transport (17), is also ex-
pressed at very high levels in B16 cells compared with other
tissues and cell lines (Fig. 2).
Immunoprecipitation of Syntaxin 7-interacting Proteins—
The high levels of Syntaxin 7 which we observed in B16 cells
gave us a good opportunity to find interacting proteins using a
coimmunoprecipitation approach. The Syntaxin 7-specific an-
tibody (Fig. 1) was covalently linked to protein A-Sepharose,
forming an affinity matrix. This was used to immunoprecipi-
tate Syntaxin 7-containing protein complexes from a B16 cell
extract. Using a non-ionic detergent solubilized extract of B16
cells we were able to immunoprecipitate Syntaxin 7 with high
efficiency and specificity (Fig. 3). Initially, to identify proteins
that interact with Syntaxin 7, immunoprecipitates were sub-
jected to SDS-PAGE followed by silver staining (Fig. 3B). We
were able to detect a number of proteins that coprecipitated
with Syntaxin 7 under these experimental conditions (see first
and fourth lanes). Most of these protein bands could not be
detected when the immunoprecipitation was performed using a
control IgG (second lane) or when the incubation with the
Syntaxin 7 antibody was performed in the presence of excess
recombinant GST-Syn7 (fifth lane). The most prominent bands
detected were of average molecular mass 230, 130, 120, 90, 35,
and 30 kDa. To identify these proteins we increased the scale of
the immunoprecipitation procedure so that bands could be
visualized by staining with Coomassie Brilliant Blue (see Fig.
3C). These bands were excised, and tryptic peptide products
were sequenced using electrospray mass spectrometry. The
FIG. 1. Specificity of the Syntaxin 7 antibody. A rabbit polyclonal
antibody was raised against a GST fusion protein containing the cytosolic
tail of Syntaxin 7. The antibody was affinity purified and used either for
immunoblotting (panel A) or immunofluorescence microscopy (B). Equal
amounts of protein (10 mg) from a B16 mouse melanoma extract were
subjected to SDS-PAGE followed by immunoblotting using either the
Syntaxin 7 antibody (lanes 1–3) or antibodies against Syntaxin 13 (lane 4)
or Syntaxin 6 (lane 5). Immunoblotting using the Syntaxin 7 antibody was
also performed in the absence or presence of either excess GST-Syn7
protein (100 mg/ml, lane 2) or excess GST-Syn13 protein (100 mg/ml, lane
3). The relative position of molecular weight markers is shown at the
right. In panel B, B16 cells were plated on glass coverslips, fixed, perme-
abilized, and immunolabeled with the Syntaxin 7 antibody alone or in the
presence of either excess GST-Syntaxin 7 (100 mg/ml) or excess GST-
Syntaxin 13 (100 mg/ml). Specific labeling was visualized using a Texas
Red-conjugated secondary antibody.
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sequences obtained are shown in Table I. Several of the bands
yielded very clear sequence data and gave positive identities
when these sequences were used for BLAST searching of the
protein data base. The doublet at 130/120 kDa contained se-
quences corresponding to the protein phosphatase 110-kDa
regulatory subunit (25) and a tyrosine kinase associated pro-
tein known as BAP-135 (26). In an effort to verify the presence
of BAP-135 in the Syntaxin 7 immunoprecipitate B16 cells
were incubated with pervanadate because this causes a
marked stimulation of BAP-135 tyrosine phosphorylation in B
cells (26). However, immunoblotting of the Syntaxin 7 immu-
noprecipitate, obtained from these cells, using a phosphoty-
rosine antibody failed to reveal any detectable product corre-
sponding to BAP-135 (data not shown). Of particular interest,
we were able to detect a number of peptide sequences in the
Syntaxin 7 immunoprecipitate corresponding to Syntaxin 7,
a-SNAP (27), mVti-1b (GenBank NP058080), and VAMP8 (28).
The t-SNARE, Syntaxin 6, was also identified in the same band
that contained a-SNAP, migrating with an average molecular
mass of 32 kDa. The abundant band at 55 kDa corresponded to
IgG. None of the other bands that were identified using this
approach yielded any detectable peptide sequences.
To verify the identity of these proteins as Syntaxin 7-inter-
acting partners we immunoblotted immunoprecipitates ob-
tained from B16 cells using antibodies specific for a variety of
these proteins. As shown in Fig. 4, Syntaxin 6, VAMP8, and
mVti1b were all enriched in the Syntaxin 7 immunoprecipitate
to almost the same extent as Syntaxin 7. None of these proteins
was present when the immunoprecipitation was performed
using preimmune serum-coated protein A beads (Fig. 4, second
lane). The immunoprecipitation efficiency of Syntaxin 7 was
;50% (Fig. 4, compare first and third lanes). In the case of
Syntaxin 6, VAMP8, and mVti1b ;20%, 20, and 10% of each
protein was coprecipitated with Syntaxin 7, indicating that
each of these proteins was highly enriched in the Syntaxin 7
complex suggesting that they likely form stable SNARE com-
plexes in vivo. It has been reported recently that another v-
SNARE, VAMP7, can play a role in the delivery of epidermal
growth factor to a degradative compartment, most likely the
late endosomal/lysosomal system, where VAMP7 is localized
(18). Although we did not detect this protein in the Syntaxin 7
immunoprecipitate by MS/MS we were able to detect coprecipi-
tation of VAMP7 with Syntaxin 7 by immunoblotting (Fig. 4).
VAMP7 was enriched in the Syntaxin 7 immunoprecipitate to
the same extent as VAMP8 (Fig. 4). Although a significant
proportion of VAMP7 was found in the Syntaxin 7 immunopre-
cipitate, our inability to detect it by MS/MS raised the possi-
bility that it may be expressed at lower abundance than other
proteins. We also immunoblotted these fractions with antibod-
ies specific for Syntaxin 4 and VAMP3 to investigate the spec-
ificity of the immunoprecipitation. Fig. 4 shows that neither
Syntaxin 4 nor VAMP3 was found in the Syntaxin 7 immuno-
precipitate to any significant extent. Although we did detect a
faint band for both proteins in the Syntaxin 7 immunoprecipi-
tate upon overexposure, this represents a very minor enrich-
ment (;1%) compared with other SNARE proteins (see above).
Immunolocalization of Syntaxin 7 and VAMP8 in B16
Cells—The identification of Syntaxin 6 as a Syntaxin 7-binding
partner was somewhat surprising because this t-SNARE has
been immunolocalized previously to the trans-Golgi network in
PC12 cells (13). However, it was clear from the immunoblotting
data (Fig. 4) that a significant amount of Syntaxin 6 coprecipi-
tates with Syntaxin 7 in B16 cells. Hence, one interpretation of
these data is that Syntaxin 6 participates in Syntaxin 7-medi-
ated fusion events as a t-SNARE light chain. To verify further
that Syntaxin 7 and Syntaxin 6 might form a complex in vivo
we conducted a series of double labeling immunolocalization
experiments (Fig. 5). First, consistent with our previous data
(14) there was very little overlap between Syntaxin 7 and the
early endosomal protein EEA1 (Fig. 5, A and B). Syntaxin 7
was localized to large vesicles scattered throughout the cyto-
plasm and clustered in the perinuclear region of the cell. Based
on our previous studies these likely correspond to late endo-
somes (14). We next compared the distribution of GFP-Syn6
with mVti1b, Syntaxin 7, and Syntaxin 13 in B16 cells. As
shown in Fig. 5, E and F, there was substantial overlap be-
tween Syntaxin 6 and Syntaxin 7, particularly in the dispersed
vesicles. There was an additional pool of Syntaxin 6 in the
perinuclear region, which did not appear to contain Syntaxin 7.
This pool presumably corresponds to the trans-Golgi network
(13). Similarly, there was also a high degree of overlap between
mVti1b and Syntaxin 6 in cytosolic vesicles. In contrast, we
observed very little if any overlap between Syntaxin 6 and
Syntaxin 13. Intriguingly, the distribution of Syntaxin 13 was
also quite distinct from EEA1 in these cells being enriched in a
very fine vesicular tubular network (Fig. 5G).
Expression of Different SNARE Proteins during Melanogen-
esis—Our earlier finding that production of Syntaxin 7 is up-
regulated upon induction of melanogenesis raised the possibil-
ity that this expression would be part of a developmental
program that would drive the coordinate expression of other
proteins that functionally interact with Syntaxin 7. Thus, to
determine if Syntaxin 7 expression correlated with the expres-
sion of the proteins we identified as interacting with Syntaxin
7, we examined lysates prepared from B16 cells at different
stages of melanosome development. The synthesis and storage
of melanin in intracellular organelles can be observed readily
as an increased deposition of dense black melanin granules or
melanosomes that are scattered throughout the cytoplasm of
the cell. As is shown in Fig. 6, a lysate prepared from B16 cells
at different stages of melanogenesis demonstrated an increased
deposition of melanin with increased time in culture. From this
time course we observed a parallel increase in the levels of
Syntaxin 7, Syntaxin 13, and the v-SNAREs, VAMP8 and
VAMP7. In contrast, the levels of Syntaxin 4 and Syntaxin 6
remained constant throughout this time course (Fig. 6). We did
note an increase in the expression of two other v-SNARE pro-
teins, VAMP2 and VAMP3. However, the time course of these
changes did not parallel the increase in melanin production.
Because of our experience with different sublines of B16 cells
behaving slightly differently, we also analyzed this phenome-
non in a B16 cell line that only underwent melanogenesis after
stimulation by a-melanocyte-stimulating hormone. Similar re-
sults were obtained in that Syntaxin 7, VAMP7, and VAMP8
FIG. 2. Expression of different SNAREs among rat tissues and
cell lines. Rat tissues were prepared as described under “Materials and
Methods” to obtain a Triton X-100-soluble total membrane extract. Ex-
tracts from either Chinese hamster ovary (CHO) or B16 cells were simi-
larly obtained. Equal amounts of lysate protein from each sample (10 mg)
were subjected to SDS-PAGE and immunoblotting with antibodies spe-
cific for the various SNARE proteins as indicated. Each antibody immu-
nolabeled one major band of the appropriate molecular mass.
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were profoundly increased, whereas levels of Syntaxin 6 and
Syntaxin 4 were unchanged.2
DISCUSSION
The conventional view is that melanosomes represent a spe-
cialized type of lysosome (24). As such, melanosomes are likely
to be derivatives of the late endosomal pathway. Previously it
has been found that the induction of melanogenesis results in
the coordinate expression of tyrosinase and lysosome-associ-
ated membrane protein 1 (29), implying that these proteins are
expressed as part of a developmental program that facilitates
the biogenesis of melanosomes. Consistent with this idea we
have found that expression of Syntaxin 7 is also induced during
melanogenesis in B16 cells (Fig. 6). Thus, it is likely that
elevated levels of Syntaxin 7 facilitate melanogenesis given the
established role of Syntaxin 7 in lysosomal biogenesis (14, 16).
We also find that the levels of the v-SNARE proteins that
interact with Syntaxin 7 are also increased upon melanocyte
differentiation, suggesting that the biochemical interactions we
observe between these proteins have significance in vivo.
Among the cohort of proteins we found associated with Syn-
taxin 7 were the Q-SNAREs, mVti1b and Syntaxin 6, and the
R-SNARE, VAMP7 (Fig. 3). Furthermore, we also found
VAMP8 associated with Syntaxin 7 in B16 cells, consistent
with our previous findings in Madin-Darby canine kidney cells
(14). The identification of these novel Syntaxin 7-binding part-
ners will permit a more detailed analysis of the composition of
the various SNARE complexes that control fusion events
within the late endocytic pathway. These interactions are best
interpreted in light of recent experiments from Rothman and
colleagues (3, 4, 30). The core SNARE complex comprises a
four-helix bundle, and this may be formed by either three or
four different proteins. One helix is contributed by the v- or
R-SNARE, which resides in the “vesicle” membrane, and the
remaining three helices are contributed by the t- or Q-SNAREs,
residing in the “target” membrane. Thus, Syntaxin 7 is pre-
dicted to regulate vesicle transport events in the late endoso-
mal system in tandem with other Q-SNAREs.
Our studies strongly suggest that mVti1b is at least one of
the relevant Q-SNARE partners for Syntaxin 7. Based on both
sequence homology and functional studies in yeast, both
mVti1a and mVti1b appear to be orthologs of the yeast Vti1p
(31). Yeast Vti1p is best characterized as a generic Q-SNARE
because it interacts with the endoplasmic reticulum to Golgi
t-SNARE, Sed5p, with the endosomal t-SNAREs, Pep12p,
Tlg1p, and Tlg2p; and with the vacuolar t-SNARE, Vam3p (5,
32–34). The identification of mVti1p as a Syntaxin 7-interact-
ing protein is consistent with the notion that Syntaxin 7 is
functionally equivalent to Vam3p in yeast (14, 15) because
Vam3p and Vti1p form a functional SNARE complex to regu-
late vacuolar transport. Thus, these results bolster the concept
that the molecular regulation of vacuolar fusion and lysosomal
fusion is highly conserved between these distinct organisms.
Consistent with previous results (14), our studies substanti-
ate an interaction between VAMP8 and Syntaxin 7. In addi-
tion, antibodies against VAMP8 that block its ability to partic-
ipate in SNARE core complex formation block homotypic fusion
of both early and late endosomes in vitro (17). These data,
combined with observations that homotypic fusion between
late endosomes is blocked by reagents designed to disrupt2 S. Richardson and R. C. Piper., unpublished data.
FIG. 3. Immunoprecipitation of Syntaxin 7-containing polypeptide complexes. Panels A and B, affinity-purified Syntaxin 7 antibodies
or an IgG control antibody was covalently linked to protein A-Sepharose beads and incubated with a detergent-solubilized B16 cell lysate in the
absence or presence of excess GST-Syn7 protein. In some cases the cell lysate was omitted from the incubation to determine which bands were
arising from beads alone. Where indicated in panel B, 500 mg of B16 lysate was included in each incubation. Samples were then subjected to
SDS-PAGE followed by either immunoblotting using the Syntaxin 7 antibody (panel A) or silver staining (panel B) to visualize protein complexes.
The relative position of molecular mass standards in the gel, which were run in parallel, is indicated at the left in panel B. Panel C, to identify some
of the proteins indicated in the first lane of panel B, the incubation of B16 extract with Syntaxin 7 antibodies was scaled up such that 400 ml of
antibody-coupled beads was incubated with 4 mg of lysate protein. Samples were subjected to SDS-PAGE followed by Coomassie Blue staining. The
bands indicated by the arrows were excised from the gel, digested with trypsin, and sequenced by electrospray ionization MS. Bands that gave
positive identifications are shown at the right of the gel, and the corresponding peptide sequences are shown in Table I. It is noteworthy that the
VAMP8 band, although not visible on this reproduction, was evident in gels freshly stained with Coomassie Blue.
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Syntaxin 7 function, suggest that Syntaxin 7 and VAMP8 are
the relevant Q- and R-SNAREs for homotypic fusion reactions
in the late endosomal pathway. However, we also find that
Syntaxin 7 is in a complex with VAMP7. The structural and
experimental models to date indicate that the three-helix Q-
SNARE subcomplex interacts with a single v-(R)-SNARE to
complete the four-helix bundle core complex (2–4, 30). Based
on these experiments it is unlikely that one SNARE complex
will contain two different R-SNARE helices. This raises the
possibility that Syntaxin 7 can form two distinct SNARE com-
plexes, one with VAMP7 and one with VAMP8. Whether a
Syntaxin 7zVAMP8 complex catalyzes fusion events that are
distinct from those catalyzed by a Syntaxin 7zVAMP7 complex
remains to be definitively determined. Like VAMP8, VAMP7
has been localized to late endosomal compartments in some cell
types and is implicated in the control of fusion events within
the late endocytic pathway (16, 18). Thus, these separate com-
plexes may control fusion of late endosomes with endosomes
derived from different origins. Alternatively, a Syntaxin
7zVAMP8zmVti1b complex may regulate homotypic fusion of
late endosomes, whereas a Sytnaxin 7zVAMP7zmVti1b complex
may facilitate fusion of late endosomes with lysosomes. Inter-
estingly, our VAMP8 antibody has no detectable effect in an in
vitro late endosome/lysosome fusion assay derived from rat
liver fractions (14), whereas VAMP7 antibodies are inhibitory
in this assay.3 To distinguish between these possibilities it will
be important to discern carefully which type of fusion events
are under investigation in these types of assay.
Based on previous structural studies and on the interaction
of Syntaxin 7 with two different v-(R)-SNAREs and the Q-
3 B. Mullock and J. P. Luzio, unpublished data.
FIG. 4. Detection of SNARE proteins in the Syntaxin 7 complex
by immunoblotting. B16 lysates were incubated with protein A beads
that had been precoated with Syntaxin 7 antibodies in the absence
(aSyn7) or presence of excess recombinant GST-Syn7 (control). These
samples together with an aliquot of B16 extract (1/10 of the starting
material used for the immunoprecipitation) were immunoblotted with
antibodies specific for Syntaxin 7, Syntaxin 6, mVti1b, VAMP3,
VAMP8, VAMP7, and Syntaxin 4.
TABLE I
Peptide sequences predicted from mass spectrometer analysis
Immunoprecipitated proteins visualized in Fig. 3 were subjected to MS analysis as described under “Materials and Methods.” Sequence matches
for the tryptic peptides obtained. Also shown is the predicted molecular mass of the complete matched protein and the apparent molecular mass
by SDS-PAGE of the excised band from which those peptide matches were derived.
Protein Sequence
Molecular mass
kDa
Predicted Measured
Protein phosphatase 1 M 110-kDa regulatory subunit, Rattus sp. aorta AQLHDTNmELTDLK 109.6 120
YDSSSTSSSDRYDSLLGR
RSTQGVTLTDLQEAEK
VGQTAFDVADEDILGYLEELQKK
BAP-135 homolog, Mus musculus TPTQTNGSNVPFKPR 110.3 115
Syntaxin 7, M. musculus ETDKYIKEFGSLPTTPSEQR 29.8 35
EKNLVSWESQTQPQVQVQDEEITEDDLR
DRLVAEFTTSLTNFQK
QLEADIMDINEIFK
DLGMMIHEQGDmIDSIEANVESAEVHVQQANQQLSR
ITQcSVEIQR
EFGSLPTTPSEQR
TLNQLGTPQDSPELR
ac-SYTPGIGGDSAQLAQR
YIKEFGSLPTTPSEQR
A-soluble SNAP, M. musculus AIAHYEQSADYYKGEESNSSANK 33.9 33
LLEAHEEQNVDSYTEAVK
HDAATcFVDAGNAFK
KADPQEAINcLMR
AIDIYEQVGTSAmDSPLLK
LLEAHEEQNVDSYTEAVKEYDSISR
NSQSFFSGLFGGSSK
LAVQKYEELFPAFSDSR
HHISIAEIYETELVDVEK
LDQWLTTMLLR
Syntaxin 6, M. musculus (low level product) IGGELEEQAVmLDDFSHELESTQSR 29.0 32
Putative v-SNARE Vtilb, M. musculus EFGSLPTTPSEQR 29.8 30
TLNQLGTPQDSPELR
LVAEFTTSLTNFQK
QLEADImDINEIFK
VAMP8, M. musculus NKTEDLEATSEHFK 11.4 15
Syntaxin 7 in Melanoma Cells 19825
 at UQ Library on September 1, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
SNARE Vti1p we would predict that at least one other protein
would be required in this complex to complete the four-helix
bundle requisite within a core complex (2–3, 30). Although this
could be accomplished by the presence of two mVti1b subunits,
we were surprised to find that in B16 cells, the most likely
protein to fulfill this role is Syntaxin 6. Syntaxin 6 was origi-
nally described as a Golgi t-SNARE that could interact with the
v-SNAREs, cellubrevin and VAMP2 (13). However, more re-
cently it has been shown that Syntaxin 6 interacts with other
SNAREs including SNAP23 (36), Syntaxin 13, and the
Q-SNARE Syntaxin 16.4 What emerges from these data is the
view that within a particular specialized cell type, SNARE
proteins may be recruited selectively to new locations to fulfill
distinct and selective functions. One particularly informative
example is the observation that in neutrophils, Syntaxin 6 is
targeted to the plasma membrane where it mediates regulated
secretion (36). Furthermore, VAMP7 also appears to be local-
ized differentially in specialized cell types such as neurons,
polarized epithelial cells, and basophils (37–39). Thus, the lo-
calization of Syntaxin 6 to late endosomal compartments in
B16 cells is consistent with this view (Fig. 5). These observa-
tions indicate that the specialized nature of different cells may
dictate the steady-state localization of SNARE proteins, thus
highlighting the potential limitation in using members of the
SNARE family as generic compartment-specific markers. Fur-
thermore, these observations require that understanding the
compartmentation and function of the endocytic system in
terms of particular SNARE proteins must be undertaken on a
cell-by-cell basis.
The significance of the association between Syntaxin 7 and
PP1M (a particular regulatory subunit of protein phosphatase
I) remains an area for future investigation. Given the abun-
dance and specificity of this protein in our immunoprecipitates
it seems likely that this protein indeed associates with Syn-
taxin 7 in vivo. Because Syntaxin 7 mediates lysosomal fusion,
a possible role for PP1M could be in the fusion process. Inter-
estingly, in vitro homotypic fusion of yeast vacuoles requires a
protein phosphatase I that is activated by calcium and calmod-
ulin (40). Although a functional role has not yet been demon-
strated for a protein phosphatase I in lysosomal fusion, there is
a requirement for calcium and calmodulin in lysosomal fusion
which mirrors the requirement for calcium and calmodulin in
homotypic vacuolar fusion (41). Intriguingly, melanosomes are
transported to the cell periphery in a manner that is dependent
on myosin Va (42) and Rab27a (43). Mouse mutations (dilute
and ashen, respectively) in these proteins result in coat color
abnormalities. Furthermore, changes in the phosphorylation
state of myosin V are correlated with its activity (44, 45). Thus
PP1M could regulate the activity of myosin V and via its
interaction with Syntaxin 7, or PP1M could regulate interac-
tion between the melanosome and myosin V. Interestingly,
movement of pigment granules in angelfish melanophores is
also blocked by inhibitors of protein phosphatase I (35).
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